Pharmagreen Biotech Inc.
Pharmagreen Biotech Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2023-06-30 | 2023-03-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-09-30 | 2020-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||
Cash | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts And Other Receivables Net Current | - | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets | - | - | 0 | - | 0 | 0 | 0 | 0 | - | 0 | 0 | |||||
Assets Current | ||||||||||||||||
Assets Current | 0 | 0 | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Accounts Receivable Net Current | 0 | 0 | - | - | 0 | - | - | - | - | - | - | |||||
Inventory Net | 0 | 0 | - | - | - | - | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | - | - | - | - | - | - | - | - | - | |||||
Notes And Loans Receivable Net Current | 0 | 0 | - | - | - | - | - | - | - | - | - | |||||
Assets | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Liabilities And Stockhold… | ||||||||||||||||
Property Plant And Equipment Net | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Liabilities | ||||||||||||||||
Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Loans Payable Current | - | - | 0 | - | - | 0 | 0 | - | 0 | 0 | 0 | |||||
Liabilities Current | ||||||||||||||||
Liabilities Current | 2 | 2 | 2 | - | 3 | 2 | 2 | 2 | 2 | 3 | 3 | |||||
Loans Payable | 0 | 0 | - | - | 0 | 0 | 0 | - | - | 0 | - | |||||
Convertible Notes Payable Current | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||||
Derivative Asset Fair Value Gross Liability | - | - | 0 | - | 1 | 0 | 0 | 0 | - | 1 | - | |||||
Derivative Liabilities Current | 0 | 0 | - | - | - | - | - | - | 0 | 1 | 2 | |||||
Due To Related Parties Noncurrent | - | 1 | - | - | - | - | - | - | - | - | - | |||||
Long Term Debt Noncurrent | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Other Loans Payable Current | - | - | - | - | - | - | - | 0 | - | - | - | |||||
Long Term Loans Payable | - | - | 0 | - | 0 | - | 0 | - | - | 0 | - | |||||
Notes Payable Related Parties Noncurrent | - | - | 0 | - | - | - | 0 | - | - | - | - | |||||
Convertible Long Term Notes Payable | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Due To Related Parties Current | - | 0 | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | 0 | |||||
Notes Payable Current | - | - | - | - | - | - | - | 0 | - | - | - | |||||
Convertible Subordinated Debt | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Liabilities | 2 | 2 | 2 | - | 3 | 2 | 2 | 2 | 2 | 3 | 3 | |||||
Stockholders Equity Inclu… | ||||||||||||||||
Equity | ||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | - | 0 | 10 | 0 | 0 | 0 | 0 | - | |||||
Common Stock Value | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Subscriptions | - | - | 0 | - | - | - | 0 | - | - | - | - | |||||
Stockholders Equity | ||||||||||||||||
Stockholders Equity | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -3 | -2 | |||||
Additional Paid In Capital | 10 | 10 | 10 | - | 10 | 0 | 10 | 9 | 9 | 4 | 4 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | 0 | 0 | - | -0 | -0 | -0 | -0 | -0 | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -13 | -13 | -13 | - | -13 | -12 | -12 | -11 | -11 | -7 | -6 | |||||
Minority Interest | -0 | -0 | -0 | - | -0 | 0 | -0 | -0 | -0 | -0 | -0 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Organization Consolidatio… | ||||||||||||||||
Debt Instrument Unamortized Discount Current | - | - | 0 | - | - | - | 0 | 0 | - | 0 | 0 | |||||
Debt Instrument Unamortized Discount Noncurrent | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Subordinated Debt Current | 0 | 0 | - | - | 0 | - | - | - | - | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | - | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | - | |||||
Preferred Stock Shares Authorized | 1 | 1 | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | - | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | - | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 2,000 | 2,000 | 2,000 | - | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 500 | |||||
Common Stock Shares Issued | 464 | 455 | 442 | - | 397 | 385 | 381 | 355 | 348 | 96 | 91 | |||||
Shares Outstanding | 464 | 455 | 442 | - | 397 | 385 | 381 | 355 | 348 | 96 | 91 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -1.54% | -32.31% | -38.46% | 6.76% | -59.46% | -70.81% | -40.74% | -48.15% | -74.07% | - | - | - |
| 2022 | 9.68% | -5.16% | -21.29% | 5.77% | -23.08% | -18.27% | -2.22% | 10.00% | -13.56% | 10.40% | 2.40% | -29.60% |
| 2021 | - | - | - | -35.12% | -34.64% | -38.34% | -9.25% | 16.68% | 10.76% | -11.06% | -23.08% | -18.27% |
| 2020 | - | - | - | - | - | - | 14.07% | -11.15% | -91.76% | 20.48% | 71.69% | 72.29% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Pharmagreen Biotech Inc. (PHBI) — SEC Financial Statements & Analysis
Pharmagreen Biotech Inc. (PHBI) is a airports, flying fields & airport terminal services company, incorporated in NV. Pharmagreen Biotech Inc. trades on OTC as: PHBI. Based on its latest SEC filing (Form 10-Q, period ending 2023-06-30), Pharmagreen Biotech Inc. reported a Debt-to-Equity ratio of -1.07x. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- -1.07x
Data as of 2023-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Pharmagreen Biotech Inc. in?
Pharmagreen Biotech Inc. (PHBI) operates in the Airports, Flying Fields & Airport Terminal Services industry.
What exchange does PHBI trade on?
Pharmagreen Biotech Inc. (PHBI) trades on the OTC.
Where is Pharmagreen Biotech Inc. incorporated?
Pharmagreen Biotech Inc. is incorporated in NV.